Michael Rink - Concepedia

Author

Michael Rink

Also Known As

Armin Soave, M Rink, M. De Rink, M. Rink, Michael RINK, Michael Rink, Redlef, John, Rink, Michael, Witjes, J. Alfred, on behalf of the EAU Young Academic Urologists—Urothelial Cancer Working party

549

Publications

12.1K

Citations

H-Index

Concepts

All Affiliations

Universität Hamburg University Medical Center Hamburg-Eppendorf Cornell University The University of Texas Southwestern Medical Center Medical University of Vienna

About

Michael Rink is an author at Universität Hamburg specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	91	4.7K
2	Public Health	4	4	338
3	Health Sciences	2	2	244
4	Engineering	1	1	12
5	Biostatistics	1	1	78

Michael Rink

168

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Thomas Powles, Piotr Tomczak, Se Hoon Park, The Lancet Oncology	2022	262
Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Évanguelos Xylinas, Michael Rink, K. Eugene, European Urology UrologySurgical OncologyDistal Ureter ManagementGenitourinary CancerMedicine	2012	251
64-slice multidetector coronary CT angiography: in vitro evaluation of 68 different stents David Maintz, Harald Seifarth, Rainer Raupach, European Radiology Different StentsHealth SciencesMedical ImagingCardiovascular DiseaseVascular Image	2005	222
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort Atiqullah Aziz, Matthias May, Maximilian Burger, European Urology Radical CystectomyUrologySurgical OncologyGenitourinary CancerMedicine	2014	203
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, European Urology	2019	189
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study Michael Rink, Felix K.‐H. Chun, Roland Dahlem, European Urology Radical CystectomySurgical OncologyHer2 ExpressionMedicineCirculating Tumor Cells	2012	184
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees Alan Horwich, Marek Babjuk, Joaquim Bellmunt, Annals of Oncology UrologyGenitourinary CancerEau–esmo Consensus StatementsMedicineCancer Management	2019	180
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy Évanguelos Xylinas, Michael Rink, Brian D. Robinson, European Journal of Cancer Radical CystectomySurgical OncologyUrologyTumoral PathologyGenitourinary Cancer	2013	170
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy Évanguelos Xylinas, Michael Rink, Vitaly Margulis, British Journal of Urology	2013	161
Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time Guillaume Ploussard, Shahrokh F. Shariat, Alice Dragomir, European Urology Radical CystectomyUrologySurgical OncologyGenitourinary CancerMedicine	2013	143

Page 1